Tango Therapeutics, Inc.

Tango Therapeutics, Inc. - Current Ratioverified

TNGX

Price:

$27.97

Market Cap:

$3.48B

Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5). This compound is currently being advanced as a potential therapy for cancers characterized by methylthioadenosine phosphorylase (MTAP) deletions. Additionally, their pipeline includes an Ubiquitin-specific protease 1 (USP1) inhibitor targeting BRCA1 or BRCA2-mutant cancers, and a program known as 'Target 3' which addresses STK11-mutant cancers. Tango Therapeutics maintains a strategic alliance with Gilead Sciences, Inc., foc...[Read more]

Industry

Biotechnology

IPO Date

2020-09-03

Stock Exchange

NASDAQ

Ticker

TNGX

The Current Ratio as of June 2026 (TTM) for Tango Therapeutics, Inc. (TNGX) is 27.38

According to Tango Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 27.38. This represents a change of 91.04% compared to the average of 14.33 of the last 4 quarters.

Tango Therapeutics, Inc. (TNGX) Historical Current Ratio (quarterly & annually)

How has TNGX Current Ratio performed in the past?

The mean historical Current Ratio of Tango Therapeutics, Inc. over the last ten years is 8.01. The current 27.38 Current Ratio has changed 34.10% with respect to the historical average. Over the past ten years (40 quarters), TNGX's Current Ratio was at its highest in in the March 2026 quarter at 27.38. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

8.01

Median

6.98

Minimum

1.61

Maximum

16.32

Tango Therapeutics, Inc. (TNGX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Tango Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 193.68%

Maximum Annual Current Ratio = 16.32

Minimum Annual Increase = -44.16%

Minimum Annual Current Ratio = 1.61

Quarterly (TTM)
Annual
YearCurrent RatioChange
202516.32133.85%
20246.98-7.50%
20237.5411.65%
20226.76-44.16%
202112.10155.68%
20204.73193.68%

Tango Therapeutics, Inc. (TNGX) Average Current Ratio

How has TNGX Current Ratio performed in the past?

The current Current Ratio of Tango Therapeutics, Inc. (TNGX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

10.28

5-year avg

9.94

10-year avg

8.01

Tango Therapeutics, Inc. (TNGX) Current Ratio vs. Peers

How is TNGX’s Current Ratio compared to its peers?

Tango Therapeutics, Inc.’s Current Ratio is greater than Septerna, Inc. (4.71), greater than UroGen Pharma Ltd. (4.69), greater than ProKidney Corp. (9.06), greater than EyePoint Pharmaceuticals, Inc. (6.66), greater than Bicara Therapeutics Inc. Common Stock (13.85), greater than Kodiak Sciences Inc. (3.54), greater than Kura Oncology, Inc. (6.15), greater than Nurix Therapeutics, Inc. (6.01), greater than Xencor, Inc. (6.57), greater than Fortrea Holdings Inc. (0.95),

Build a custom stock screener for Tango Therapeutics, Inc. (TNGX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tango Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tango Therapeutics, Inc. (TNGX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tango Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Tango Therapeutics, Inc.'s Current Ratio?

How is the Current Ratio calculated for Tango Therapeutics, Inc. (TNGX)?

What is the highest Current Ratio for Tango Therapeutics, Inc. (TNGX)?

What is the 3-year average Current Ratio for Tango Therapeutics, Inc. (TNGX)?

What is the 5-year average Current Ratio for Tango Therapeutics, Inc. (TNGX)?

How does the current Current Ratio for Tango Therapeutics, Inc. (TNGX) compare to its historical average?